首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1935167

免疫组库定序市场：依产品类型、应用、最终用户、地区划分

Immune Repertoire Sequencing Market, By Product Type, By Application, By End User, By Geography

出版日期: 2026年01月21日 | 出版商:

Coherent Market Insights | 英文 200 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计到 2026 年，免疫组库定序市场价值将达到 1.811 亿美元，预计到 2033 年将达到 2.63 亿美元，2026 年至 2033 年的复合年增长率为 5.6%。

报告覆盖范围		报告详情
基准年：	2025	2026年市场规模：	1.811亿美元
历史数据时期：	2020年至2024年	预测期：	2026年至2033年
预测期（2026-2033年）复合年增长率：	5.60%	2033 年的预测值：	2.63亿美元

免疫库是指生物体免疫系统产生的蛋白质亚型。脊椎动物免疫系统主要包含六种蛋白质：两种免疫球蛋白和四种T细胞受体。免疫库定序技术使研究人员和科学家能够研究和了解涉及适应性免疫的疾病。免疫库定序也广泛应用于生物标记发现、感染疾病研究、气喘和过敏研究以及癌症免疫治疗。

市场动态

全球癌症发生率的不断上升预计将推动免疫组库定序市场的成长。根据美国国家癌症研究所（2016年）统计，美国每年新增癌症病例约1,680万例，约59,5,690人死于癌症。此外，预计到2024年，癌症患者人数将达到1,900万人。根据2012年《癌症地图集》，拉丁美洲和加勒比海地区每年报告约110万例新增癌症病例和60万例癌症死亡病例，其中肺癌是男性和女性癌症死亡的首要原因。

然而，特定定序平台和数据分析服务的高成本以及产品召回等因素预计将在预测期内阻碍免疫组库定序市场的成长。例如，2015年，Illumina公司召回了Illumina MiSeqDx Universal Kit 1.0，原因是该试剂盒与MiSeqDx仪器配合使用时存在软体缺陷。软体无法报告与引子相关的特定基因组位置的插入或缺失。

本次调查的主要特点

本报告详细分析了免疫组库定序市场、市场规模以及以 2025 年为基准年预测期（2026-2033 年）的复合年增长率（%）。
该报告重点介绍了各个细分市场的潜在商机，并为该市场说明了一个具有吸引力的投资提案矩阵。
该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
本报告根据以下参数对全球免疫组库定序市场的主要参与者进行了分析：公司概况、财务表现、产品系列、地理扩张、分销策略、关键发展和策略。
本报告的研究结果将使企业负责人和经营团队能够就未来的产品发布、政府措施、技术升级、市场扩张和行销策略做出明智的决策。
这份全球免疫库定序市场报告对产业内的各种相关人员很有用，包括投资者、产品製造商、经销商、供应商、研究和咨询公司、新参与企业和金融分析师。

北美洲
- 我们
- 加拿大
欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲
亚太地区
- 中国
- 日本
- 印度
- ASEAN
- 澳洲
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲国家
非洲
- 北非
- 中非
- 南非
中东
- 海湾合作委员会国家
- 以色列
- 其他中东国家

第八章竞争情势

公司简介
- Thermo Fisher Scientific, Inc.
- Illumina Inc.
- ArcherDX, Inc.
- Roche Holding AG
- Pacific Biosciences
- CD Genomics
- Atreca, Inc.
- Adaptive Biotechnologies
- Oxford Nanopore Technologies, Ltd.
- Qiagen NV
- Agilent Technologies, Inc.
- Takara Bio, Inc.

第九章各节

参考
调查方法

简介目录

Product Code: CMI1517

Immune Repertoire Sequencing Market is estimated to be valued at USD 181.1 Mn in 2026 and is expected to reach USD 263.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 181.1 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.60%	2033 Value Projection:	USD 263.0 Mn

Immune repertoire refers to sub-type protein that an organism's immune system creates. Immune systems in vertebrates have six key types of proteins- two immunoglobulin and four T cell receptors. Immune repertoire sequencing enables researchers and scientists to examine and understand adaptive immune-mediated diseases. Immune repertoire sequencing is also widely applicable in biomarker discovery, infectious disease research, asthma and allergy research, and cancer immunotherapy.

Market Dynamics

Increasing prevalence of cancer worldwide is expected to boost immune repertoire sequencing market growth. According to National Cancer Institute, 2016, an estimated 16.8 million new cases of cancer were diagnosed in the U.S., with around 595,690 deaths from the disease. Moreover, the number of people suffering from cancer is expected to reach to 19 million by 2024. According to the Cancer Atlas, 2012, about 1.1 million new cancer cases and 600,000 cancer deaths are reported annually in Latin America and the Caribbean, where lung cancer is the leading cause of cancer death for both sexes.

However, factors such as high cost associated with certain sequencing platforms and data analytic services coupled with product recalls are expected to hinder growth of the immune repertoire sequencing market during the forecast period. For instance, in 2015, Illumina Inc. recalled its Illumina MiSeqDx Universal Kit 1.0, due to software limitation when using the product on MiSeqDx instrument. The software could not report insertions or deletions at specific genomic locations with respect to the primer.

Key features of the study

This report provides in-depth analysis of the immune repertoire sequencing market, market size (USD Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2026 - 2033, considering 2025 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global immune repertoire sequencing market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Thermo Fisher Scientific, Inc., Illumina Inc., ArcherDX, Inc., Roche Holding AG, Pacific Biosciences, CD Genomics, Atreca, Inc., Adaptive Biotechnologies, Oxford Nanopore Technologies, Ltd., Qiagen N.V., Agilent Technologies, Inc., and Takara Bio, Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global immune repertoire sequencing market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for immune repertoire sequencing market, research and consulting firms, new entrants, and financial analysts

Market Segmentation

By Product Type
- Assay Kits
- T-Cell Receptor (TCR) Kits
- B-Cell Receptor (BCR) Kits
- Instruments
By Application
- Cancer Immunotherapy
- Biomarker Discovery
- Autoimmune Diseases
- Vaccine Development and Efficacy
- Transplant Rejection and Tolerance
- Infectious Diseases
- Other Applications
By End User
- Diagnostic Labs
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institutes
- Others
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Key Players Insights
- Thermo Fisher Scientific, Inc.,
- Illumina Inc.
- ArcherDX, Inc.
- Roche Holding AG
- Pacific Biosciences
- CD Genomics, Atreca, Inc.
- Adaptive Biotechnologies
- Oxford Nanopore Technologies, Ltd.
- Qiagen N.V.
- Agilent Technologies, Inc.
- Takara Bio, Inc.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Landscape
Product Recall
Epidemiology Analysis
Technology Overview
PEST Analysis
Porter's Five Forces model

4. Global Immune Repertoire Sequencing Market, By Product Type, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Assay Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
T-Cell Receptor (TCR) Kits
B-Cell Receptor (BCR) Kits
Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. Global Immune Repertoire Sequencing Market, By Application, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Cancer Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Biomarker Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Vaccine Development and Efficacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Transplant Rejection and Tolerance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. Global Immune Repertoire Sequencing Market, By End User, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Diagnostic Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Biotechnology and Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

7. Global Immune Repertoire Sequencing Market, By Region, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, By Region, 2026 - 2033
- Regional Trends
North America
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - U.S.
  - Canada
Europe
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - China
  - Japan
  - India
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Africa
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa
Middle East
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East

8. Competitive Landscape

Company Profiles
- Thermo Fisher Scientific, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Illumina Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- ArcherDX, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Roche Holding AG
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Pacific Biosciences
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- CD Genomics
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Atreca, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Adaptive Biotechnologies
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Oxford Nanopore Technologies, Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Qiagen N.V.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Agilent Technologies, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Takara Bio, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
  - Analyst Views

9. Section

References
Research Methodology
About Us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

免疫组库定序市场：依产品类型、应用、最终用户、地区划分

Immune Repertoire Sequencing Market, By Product Type, By Application, By End User, By Geography

市场动态